Characterizing the fusogenicity of SARS-CoV-2 variants via Spike protein-mediated membrane fusion assay. The 23rd Kumamoto AIDS seminar, Kumamoto, Japan.

Nasser H, Suzuki R, Kishimoto M, Shimizu R, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Sato K, Matsuno K, Fukuhara T, Ikeda T. Characterizing the fusogenicity of SARS-CoV-2 variants via Spike protein-mediated membrane fusion assay. The 23rd Kumamoto AIDS seminar, Kumamoto, Japan. Oct 31-Nov 2, 2022.